Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
What's at stake
Compared with long-acting insulin, GLP-1RA therapy reduces the risk of composite liver disease (cirrhosis or hepatocellular carcinoma) in patients with type 2 diabetes by 44%, with a 41% reduction in cirrhosis risk and a 53% reduction in hepatocellular carcinoma risk
10.1016/j.jacc.2020.11.010 48 SaadhM
And faith is a poor substitute for data when you are injecting a substance into your body
US$ 25.55
US$ 21.71
US$ 24.81
US$ 21.05
US$ 21.10
US$ 21.62
US$ 21.51
US$ 21.11
US$ 22.59
